Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 16, 2025Current Pharmaceutical Design

Unraveling the Complexity of Polycystic Ovary Syndrome: Biomarkers for Diagnosis, Prognosis, and Treatment

View Full Paper
Ask AI
Bookmark
Share

Authors

SUSaloni UpadhyayAMAvijit MazumderSDSaumya Das

Discussion

Loading...

Member takes

Overview

This review identifies major biomarkers in diagnosing and managing polycystic ovary syndrome, suggesting methods to improve patient outcomes.

Key Points

  • Biomarkers can optimize the diagnosis and treatment of polycystic ovary syndrome, enhancing patient management.
  • The review highlights crucial biomarkers such as insulin and anti-Mullerian hormone linked to polycystic ovary syndrome.
  • Diagnosing polycystic ovary syndrome involves assessing features like ovulatory dysfunction and hyperandrogenism.
  • Controlling disease markers may help alleviate symptoms and reduce the risk of associated conditions.

Cite This Study

Upadhyay et al. (2025) studied this question.

synapsesocial.com/papers/68d4204e713b0b5dfea68f84https://doi.org/10.2174/0113816128382284250822045319
View Full Paper
Ask AI
Bookmark
Share